Search results
This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.
- SARS CoV-2: Progression and treatment protocols – An overview
The SARS-CoV-2 belongs to a group of RNA viruses which...
- SARS CoV-2: Progression and treatment protocols – An overview
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention.
Getting vaccinated against COVID-19 as soon as it’s your turn is the best way to reduce your risk of contracting the disease or developing severe symptoms.
17 wrz 2021 · The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for treatment are still...
9 wrz 2020 · With the increasing rise in the number of infected persons and death rate, more drugs/therapeutic agents and treatment for SARS-CoV-2 virus are required.
6 paź 2020 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory...
19 mar 2021 · The SARS-CoV-2 belongs to a group of RNA viruses which predominantly cause respiratory illness in mammals and contains other lethal varieties such as severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). It belongs to family Coronaviridae and order Nidovirales [1a].
